Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6738084 | 7409573 | I | 6738084-8 | 20100511 | 20100520 | EXP | TCI2010A01781 | TAKEDA PHARAMACEUTICALS NORTH AMERICA. | 68 | YR | F | N | 20100519 | JAPAN |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6738084 | 1013738503 | PS | ACTOS | 1 | ORAL | 15 MG (15 MG, 1-2), PER ORAL | Y | D | 21073 | ||
6738084 | 1013757470 | SS | PHENYTOIN | 1 | 200 MG (200 MG, 1 D); | ||||||
6738084 | 1013757472 | SS | GLIMEPIRIDE | 1 | ORAL | 1 MG (1 MG, 1 D), PER ORAL |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6738084 | 1013738503 | TYPE 2 DIABETES MELLITUS |
6738084 | 1013757472 | TYPE 2 DIABETES MELLITUS |
Outcome of event
Event ID | OUTC COD |
---|---|
6738084 | OT |
Reactions reported
Event ID | PT |
---|---|
6738084 | DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
6738084 | GENERALISED ERYTHEMA |
6738084 | HEPATIC ENZYME INCREASED |
6738084 | PRURITUS |
6738084 | PYREXIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | RPSR COD |
---|---|
6738084 | HP |
6738084 | LIT |
Therapies reported
no results found |